hrp0094gped1.1 | The use of long-acting insulin analogues in low and middle income countries | ESPE2021
Quality of care of children living with diabetes varies widely around the world. Since discovering of insulin a hundred years ago, its still unavailable for a large part of children living with diabetes in developing world. According to World Health Organisation (2019), less than 13% of people living with diabetes in these countries have access to long acting insulin analogues. Thus, primary challenges of management of type I diabetes is reduction of mortality especially...